{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:52Z","timestamp":1787071012305,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To investigate the influencing factors of transcatheter arterial chemoembolization (TACE) on patients with hepatocellular carcinoma (HCC) for tumor response (complete and partial response, CR + PR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This research conducted a retrospective study of the hospital charts of patients treated with TACE successfully renewed from October 2014 to December 2015 at Sun Yat-sen University Cancer Center (Guangzhou, China). Univariate analysis (Chi-square test and repeated-measures ANOVA) selected nine influential tumor response factors from 22 core factors. The nine variables were included in a forward multiple logistic regression model predicting patients treated with TACE to achieve tumor response. Overall survival was calculated using the Kaplan\u2013Meier method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Data of 277 of 282 patients were included in the analysis. Nine variables were analyzed by univariate analysis and independently associated with tumor response (tumor capsule integrity, nausea and vomiting, microwave ablation, liver dysfunction, the absolute value of lymphocyte (LYM), alpha-fetoprotein, and gamma-glutamyl transpeptidase (GGT). By multivariate analysis, GGT (odds ratio [OR] =0.996), liver dysfunction (OR = 0.395), combined with microwave ablation (OR = 0.503), and tumor capsule integrity (OR = 1.894) were the significant predictors of the tumor response group compared with the standard deviation group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study suggests that TACE combined with ablation on patients with complete tumor capsules may have a better prognosis in tumor response and OS; additionally, liver dysfunction and nausea and vomiting were the independent predictors of tumor response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_852_21","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T06:10:28Z","timestamp":1679897428000},"page":"560-566","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response"],"prefix":"10.4103","volume":"18","author":[{"given":"Hongyan","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-33-20241021","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/cncr.30237","article-title":"Comparison of hepatocellular carcinoma in eastern versus western populations","volume":"122","author":"Choo","year":"2016","journal-title":"Cancer"},{"key":"R2-33-20241021","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ijc.30211","article-title":"International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007","volume":"139","author":"Petrick","year":"2016","journal-title":"Int J Cancer"},{"key":"R3-33-20241021","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1590\/0102-6720201700040011","article-title":"Hepatocellular carcinoma: Diagnosis and operative management","volume":"30","author":"Chedid","year":"2017","journal-title":"Arq Bras Cir Dig"},{"key":"R4-33-20241021","doi-asserted-by":"crossref","first-page":"319","DOI":"10.6009\/jjrt.2017_JSRT_73.4.319","article-title":"Surgical treatment of hepatocellular carcinoma","volume":"73","author":"Matsuda","year":"2017","journal-title":"Nihon Hoshasen Gijutsu Gakkai Zasshi"},{"key":"R5-33-20241021","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.3748\/wjg.v24.i40.4527","article-title":"Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus","volume":"24","author":"Peng","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R6-33-20241021","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/jhep.2000.9033","article-title":"Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases","volume":"32","author":"Bralet","year":"2000","journal-title":"Hepatology"},{"key":"R7-33-20241021","first-page":"3145","article-title":"Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma","volume":"17","author":"Gao","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R8-33-20241021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ctr.12089","article-title":"Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation","volume":"27","author":"Kim","year":"2013","journal-title":"Clin Transplant"},{"key":"R9-33-20241021","doi-asserted-by":"crossref","first-page":"W211","DOI":"10.2214\/AJR.16.17398","article-title":"Prediction of therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization based on pretherapeutic dynamic CT and textural findings","volume":"209","author":"Park","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"R10-33-20241021","doi-asserted-by":"crossref","first-page":"e71942","DOI":"10.1371\/journal.pone.0071942","article-title":"Ectopic blood supply of hepatocellular carcinoma as depicted by angiography with computed tomography: Associations with morphological features and therapeutic history","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"R11-33-20241021","doi-asserted-by":"crossref","first-page":"e10890","DOI":"10.1097\/MD.0000000000010890","article-title":"Transcatheter arterial chemoembolization (TACE) combined with \u03b3-knife compared to TACE or \u03b3-knife alone for hepatocellular carcinoma","volume":"97","author":"Cai","year":"2018","journal-title":"Medicine (Baltimore"},{"key":"R12-33-20241021","doi-asserted-by":"crossref","first-page":"17939","DOI":"10.1038\/srep17939","article-title":"Gene silencing of TACE enhances plaque stability and improves vascular remodeling in a rabbit model of atherosclerosis","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci Rep"},{"key":"R13-33-20241021","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.7314\/APJCP.2012.13.7.3191","article-title":"Association between insulin-like growth factor-2 expression and prognosis after transcatheter arterial chemoembolization and octreotide in patients with hepatocellular carcinoma","volume":"13","author":"Xiong","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"R14-33-20241021","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"R16-33-20241021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"R17-33-20241021","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"key":"R18-33-20241021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1478-3231.1999.tb00017.x","article-title":"Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor","volume":"19","author":"Itoh","year":"1999","journal-title":"Denmark Liver"},{"key":"R19-33-20241021","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1148\/radiology.185.2.1329143","article-title":"Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization","volume":"185","author":"Tanaka","year":"1992","journal-title":"Radiology"},{"key":"R20-33-20241021","first-page":"8619096","article-title":"The combination strategy of transarterial chemoembolization and radiofrequency ablation or microwave ablation against hepatocellular carcinoma","volume":"2019","author":"Xu","year":"2019","journal-title":"Anal Cell Pathol (Amst"},{"key":"R21-33-20241021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40644-020-0294-5","article-title":"Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Imaging"},{"key":"R22-33-20241021","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jvir.2019.06.006","article-title":"Chemoembolization combined with radiofrequency ablation for medium-sized hepatocellular carcinoma: A propensity-score analysis","volume":"30","author":"Chu","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R23-33-20241021","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2214\/AJR.17.18177","article-title":"Transcatheter arterial chemoembolization with or without radiofrequency ablation: Outcomes in patients with barcelona clinic liver cancer stage B hepatocellular carcinoma","volume":"210","author":"Hirooka","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"R24-33-20241021","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.3748\/wjg.v19.i24.3872","article-title":"Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma","volume":"19","author":"Ni","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R25-33-20241021","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00261-019-01952-1","article-title":"Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: Comparison with TACE or RFA monotherapy","volume":"44","author":"Kim","year":"2019","journal-title":"Abdom Radiol (NY"},{"key":"R26-33-20241021","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00280-018-3638-0","article-title":"Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"82","author":"Choi","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"R27-33-20241021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000473887","article-title":"Sorafenib versus hepatic arterial infusion chemotherapy as initial treatment for hepatocellular carcinoma with advanced portal vein tumor thrombosis","volume":"6","author":"Moriguchi","year":"2017","journal-title":"Liver Cancer"},{"key":"R28-33-20241021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000507370","article-title":"A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements","volume":"9","author":"Kudo","year":"2020","journal-title":"Liver Cancer"},{"key":"R29-33-20241021","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000489791","article-title":"Patients with Barcelona clinic liver cancer stages B and C hepatocellular carcinoma: Time for a subclassification","volume":"8","author":"Golfieri","year":"2019","journal-title":"Liver Cancer"},{"key":"R30-33-20241021","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.7314\/APJCP.2013.14.10.5995","article-title":"Nausea and vomiting after transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence and risk factor analysis","volume":"14","author":"Wang","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"R31-33-20241021","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2174\/1573405615666181122145330","article-title":"Risk factors for postembolization syndrome after transcatheter arterial chemoembolization","volume":"15","author":"Arslan","year":"2019","journal-title":"Curr Med Imaging Rev"},{"key":"R32-33-20241021","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/NCC.0000000000000302","article-title":"Management of postembolization syndrome following hepatic transarterial chemoembolization for primary or metastatic liver cancer","volume":"39","author":"Blackburn","year":"2016","journal-title":"Cancer Nurs"},{"key":"R33-33-20241021","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jvir.2017.07.021","article-title":"Dexamethasone prophylaxis to alleviate postembolization syndrome after transarterial chemoembolization for hepatocellular carcinoma: A randomized, double-blinded, placebo-controlled study","volume":"28","author":"Yang","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"R34-33-20241021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000497460","article-title":"Objective response by mRECIST is an independent prognostic factor of overall survival in systemic therapy for hepatocellular carcinoma","volume":"8","author":"Kudo","year":"2019","journal-title":"Liver Cancer"},{"key":"R35-33-20241021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.5152\/dir.2020.19615","article-title":"TACE combined with microwave ablation therapy vs. TACE alone for treatment of early- and intermediate-stage hepatocellular carcinomas larger than 5 cm: A meta-analysis","volume":"26","author":"Liu","year":"2020","journal-title":"Diagn Interv Radiol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_852_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:20Z","timestamp":1787067620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_852_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_852_21","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}